-
Evolving JCA Perspectives From EU Stakeholders and the Impact on Manufacturers
Sep 9, 2025, 16:22 PM -
Psychometric Performance of EQ-HWB for Japanese Populations
Sep 9, 2025, 16:22 PM -
Development of a New, Adaptable Patient-Reported Outcome Measure of Treatment Satisfaction
Sep 9, 2025, 16:22 PM -
Distributional Cost-Effectiveness Analysis Across the Globe: How Feasible Is It Really?
Sep 9, 2025, 16:22 PM -
Landscape of Data Sources for Real-World Observational Studies: Focus on the French Context
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Traditional vs. Generative AI: A Rapid Systematic Review Assessing Accuracy and Efficiency of AI in Title/Abstract Screening
Sep 9, 2025, 16:22 PM -
Evaluating the Lifetime Incremental Value of Pharmaceutical Innovation: The Case of Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair, Proficient Mismatch Repair, and Intention-to-Treat Populations From the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Exploration of the Utility of Linguistic Validation Cognitive Debriefing Interviews in Generating Evidence for Adding or Modifying Source COA Content
Sep 9, 2025, 16:22 PM -
Obesity and MASH in the UK
Sep 9, 2025, 16:22 PM -
Micro-Costing Analysis of the Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis and Its Comorbidities in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Economic Burden Of Primary Biliary Cholangitis (PBC) in Spain
Sep 9, 2025, 16:22 PM -
Transition Across Cognitive States and Death Among Older Adults With Type 2 Diabetes: Determining the Predictors of Cognitive Decline With a Multistate Markov Model
Sep 9, 2025, 16:22 PM -
Assessing the Use of Artificial Intelligence in Publication-Grade Research: A Literature Review of Applications in HEOR
Sep 9, 2025, 16:22 PM -
English Translation, Cross-Cultural Adaptation and Validation of the French New Patient-Reported Outcome Measures of the Multiple Sclerosis Autonomy Scale (MSAS)
Sep 9, 2025, 16:22 PM -
Evaluating the Potential Health and Economic Impact of V116 vs. PCV20 on Invasive Pneumococcal Disease Among Adults in the United Kingdom
Sep 9, 2025, 16:22 PM -
Provisional Listing of Digital Healthcare Applications Digas Improves Patients' Access to Healthcare in Germany
Sep 9, 2025, 16:22 PM -
Surrogate Endpoints in German Health Technology Assessment: Post Hoc Analyses of the Phase III PROTECT Study Highlight the Efficacy of Sparsentan in Slowing Down the Loss of Kidney Function in IgAN Patients
Sep 9, 2025, 16:22 PM -
Navigating Three Systems: A Comparative Analysis of Pharmaceutical Reimbursement in Germany, Austria, and Switzerland
Sep 9, 2025, 16:22 PM
